(Q44302465)

1 December 2017

title

Past, present and future: 30 years of HIV research (English)

1 reference

1 December 2017

author

Françoise Barré-Sinoussi

series ordinal

1

object named as

Françoise Barré-Sinoussi

1 reference

1 December 2017

Jean-François Delfraissy

series ordinal

3

object named as

Jean-François Delfraissy

0 references

Anna Laura Ross

series ordinal

2

object named as

Anna Laura Ross

1 reference

1 December 2017

language of work or name

English

0 references

publication date

28 October 2013

1 reference

Nature Reviews Microbiology

1 December 2017

published in

1 reference

1 December 2017

volume

11

1 reference

1 December 2017

issue

12

1 reference

1 December 2017

page(s)

877-883

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro3132

1 December 2017

exact match

0 references

cites work

Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Serological Analysis of a Subgroup of Human T-Lymphotropic Retroviruses (HTLV-III) Associated with AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Molecular cloning and characterization of the HTLV-III virus associated with AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Molecular cloning of AIDS-associated retrovirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Molecular cloning of lymphadenopathy-associated virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Nucleotide sequence of the AIDS virus, LAV

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Nucleotide sequence and expression of an AIDS-associated retrovirus (ARV-2).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Molecular organization of the AIDS retrovirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

An African primate lentivirus (SIVsm) closely related to HIV-2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Thirty years on: HIV receptor gymnastics and the prevention of infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

The evolutionary rate of nonpathogenic simian immunodeficiency virus (SIVagm) is in agreement with a rapid and continuous replication in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

HIV-1 adaptation to NK-cell-mediated immune pressure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Preexposure prophylaxis for HIV infection among African women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Prevention of HIV-1 infection with early antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Long-term HIV-1 infection without immunologic progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Depletion of latent HIV-1 infection in vivo: a proof-of-concept study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Antibody neutralization and escape by HIV-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Broad neutralization coverage of HIV by multiple highly potent antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Anti-HIV IgA isotypes: differential virion capture and inhibition of transcytosis are linked to prevention of mucosal R5 SHIV transmission

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO3132

Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24162027

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24162027

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRMICRO3132

1 reference

1 December 2017

1 reference